GetTopicDetailResponse(id=63b012414eae, topicName=再誘導(dǎo)治療, introduction=, content=急性髓系白血病 再誘導(dǎo)治療, image=null, comments=0, allHits=275, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Wed Feb 12 14:56:58 CST 2025, time=2025-02-12, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=501400, tagList=[TagDto(tagId=501400, tagName=再誘導(dǎo)治療)], ipAttribution=陜西省, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2251617, encodeId=d95f225161e91, content=<a href='/topic/show?id=eb2152482d7' target=_blank style='color:#2F92EE;'>#急性髓系白血病#</a> <a href='/topic/show?id=63b012414eae' target=_blank style='color:#2F92EE;'>#再誘導(dǎo)治療#</a>, objectTitle=【Leukemia】7+3或大劑量阿糖胞苷再誘導(dǎo)的緩解率較高，試驗(yàn)性再誘導(dǎo)方案可能需謹(jǐn)慎, objectType=article, longId=862905, objectId=2146862905d1, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220801/1659342224826_8252897.webp, objectUrl=/article/show_article.do?id=2146862905d1, replyNumber=0, likeNumber=40, createdTime=2025-02-12, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=2146862905d1, moduleTitle=【Leukemia】7+3或大劑量阿糖胞苷再誘導(dǎo)的緩解率較高，試驗(yàn)性再誘導(dǎo)方案可能需謹(jǐn)慎, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=2146862905d1)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-02-12發(fā)表于陜西省
